Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Feb;106(Suppl 1):231–239. doi: 10.1289/ehp.106-1533289

Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects.

R J Srám 1
PMCID: PMC1533289  PMID: 9539016

Abstract

Genotypes responsible for interindividual differences in ability to activate or detoxify genotoxic agents are recognized as biomarkers of susceptibility. Among the most studied genotypes are human glutathione transferases. The relationship of genetic susceptibility to biomarkers of exposure and effects was studied especially in relation to the genetic polymorphism of glutathione S-transferase M1 (GSTM1). For this review papers reporting the effect of GSTM1 genotype on DNA adducts, protein adducts, urine mutagenicity, Comet assay parameters, chromosomal aberrations, sister chromatid exchanges (SCE), micronuclei, and hypoxanthine-guanine phosphoribosyl transferase mutations were assessed. Subjects in groups occupationally exposed to polycyclic aromatic hydrocarbons, benzidine, pesticides, and 1,3-butadiene were included. As environmentally exposed populations, autopsy donors, coal tar-treated patients, smokers, nonsmokers, mothers, postal workers, and firefighters were followed. From all biomarkers the effect of GSTM1 and N-acetyl transferase 2 was seen in coke oven workers on mutagenicity of urine and of glutathione S-transferase T1 on the chromosomal aberrations in subjects from 1,3-butadiene monomer production units. Effects of genotypes on DNA adducts were found from lung tissue of autopsy donors and from placentas of mothers living in an air-polluted region. The GSTM1 genotype affected mutagenicity of urine in smokers and subjects from polluted regions, protein adducts in smokers, SCE in smokers and nonsmokers, and Comet assay parameters in postal workers. A review of all studies on GSTM1 polymorphisms suggests that research probably has not reached the stage where results can be interpreted to formulate preventive measures. The relationship between genotypes and biomarkers of exposure and effects may provide an important guide to the risk assessment of human exposure to mutagens and carcinogens.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertini R. J., Nicklas J. A., O'Neill J. P. Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environ Health Perspect. 1996 May;104 (Suppl 3):503–510. doi: 10.1289/ehp.96104s3503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexandrie A. K., Sundberg M. I., Seidegård J., Tornling G., Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994 Sep;15(9):1785–1790. doi: 10.1093/carcin/15.9.1785. [DOI] [PubMed] [Google Scholar]
  3. Anttila S., Luostarinen L., Hirvonen A., Elovaara E., Karjalainen A., Nurminen T., Hayes J. D., Vainio H., Ketterer B. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res. 1995 Aug 1;55(15):3305–3309. [PubMed] [Google Scholar]
  4. Autrup H., Vestergaard A. B., Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis. 1995 Jun;16(6):1305–1309. doi: 10.1093/carcin/16.6.1305. [DOI] [PubMed] [Google Scholar]
  5. Barrett J. C., Vainio H., Peakall D., Goldstein B. D. 12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards. Environ Health Perspect. 1997 Jun;105 (Suppl 4):699–737. doi: 10.1289/ehp.97105s4699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bartsch H., Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect. 1996 May;104 (Suppl 3):569–577. doi: 10.1289/ehp.96104s3569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Binková B., Lewtas J., Mísková I., Rössner P., Cerná M., Mrácková G., Peterková K., Mumford J., Meyer S., Srám R. Biomarker studies in northern Bohemia. Environ Health Perspect. 1996 May;104 (Suppl 3):591–597. doi: 10.1289/ehp.104-1469612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bonassi S., Abbondandolo A., Camurri L., Dal Prá L., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet. 1995 Feb;79(2):133–135. doi: 10.1016/0165-4608(94)00131-t. [DOI] [PubMed] [Google Scholar]
  9. Brockmöller J., Kerb R., Drakoulis N., Nitz M., Roots I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 1993 Mar 1;53(5):1004–1011. [PubMed] [Google Scholar]
  10. Carstensen U., Alexandrie A. K., Högstedt B., Rannug A., Bratt I., Hagmar L. B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu). Mutat Res. 1993 Oct;289(2):187–195. doi: 10.1016/0027-5107(93)90069-r. [DOI] [PubMed] [Google Scholar]
  11. Cheng T. J., Christiani D. C., Liber H. L., Wain J. C., Xu X., Wiencke J. K., Kelsey K. T. Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer. Mutat Res. 1995 Nov;332(1-2):109–118. doi: 10.1016/0027-5107(95)00161-8. [DOI] [PubMed] [Google Scholar]
  12. Cheng T. J., Christiani D. C., Wiencke J. K., Wain J. C., Xu X., Kelsey K. T. Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat Res. 1995 Oct;348(2):75–82. doi: 10.1016/0165-7992(95)00049-6. [DOI] [PubMed] [Google Scholar]
  13. Cheng T. J., Christiani D. C., Xu X., Wain J. C., Wiencke J. K., Kelsey K. T. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):535–542. [PubMed] [Google Scholar]
  14. Cheng T. J., Christiani D. C., Xu X., Wain J. C., Wiencke J. K., Kelsey K. T. Increased micronucleus frequency in lymphocytes from smokers with lung cancer. Mutat Res. 1996 Jan 17;349(1):43–50. doi: 10.1016/0027-5107(95)00150-6. [DOI] [PubMed] [Google Scholar]
  15. Coles B., Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol. 1990;25(1):47–70. doi: 10.3109/10409239009090605. [DOI] [PubMed] [Google Scholar]
  16. Gabbani G., Hou S. M., Nardini B., Marchioro M., Lambert B., Clonfero E. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis. 1996 Aug;17(8):1677–1681. doi: 10.1093/carcin/17.8.1677. [DOI] [PubMed] [Google Scholar]
  17. Grinberg-Funes R. A., Singh V. N., Perera F. P., Bell D. A., Young T. L., Dickey C., Wang L. W., Santella R. M. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. Carcinogenesis. 1994 Nov;15(11):2449–2454. doi: 10.1093/carcin/15.11.2449. [DOI] [PubMed] [Google Scholar]
  18. Hagmar L., Brøgger A., Hansteen I. L., Heim S., Högstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 1994 Jun 1;54(11):2919–2922. [PubMed] [Google Scholar]
  19. Harris C. C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 1991 Sep 15;51(18 Suppl):5023s–5044s. [PubMed] [Google Scholar]
  20. Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res. 1992 Aug;83(8):866–870. doi: 10.1111/j.1349-7006.1992.tb01992.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Heckbert S. R., Weiss N. S., Hornung S. K., Eaton D. L., Motulsky A. G. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J Natl Cancer Inst. 1992 Mar 18;84(6):414–422. doi: 10.1093/jnci/84.6.414. [DOI] [PubMed] [Google Scholar]
  22. Hemminki K., Dickey C., Karlsson S., Bell D., Hsu Y., Tsai W. Y., Mooney L. A., Savela K., Perera F. P. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis. 1997 Feb;18(2):345–350. doi: 10.1093/carcin/18.2.345. [DOI] [PubMed] [Google Scholar]
  23. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med. 1995 Jan;37(1):37–43. doi: 10.1097/00043764-199501000-00006. [DOI] [PubMed] [Google Scholar]
  24. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 1993 Jul;14(7):1479–1481. doi: 10.1093/carcin/14.7.1479. [DOI] [PubMed] [Google Scholar]
  25. Hirvonen A., Nylund L., Kociba P., Husgafvel-Pursiainen K., Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis. 1994 May;15(5):813–815. doi: 10.1093/carcin/15.5.813. [DOI] [PubMed] [Google Scholar]
  26. Hou S. M., Fält S., Steen A. M. Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ Mol Mutagen. 1995;25(2):97–105. doi: 10.1002/em.2850250203. [DOI] [PubMed] [Google Scholar]
  27. Hou S. M., Lambert B., Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis. 1995 Aug;16(8):1913–1917. doi: 10.1093/carcin/16.8.1913. [DOI] [PubMed] [Google Scholar]
  28. Hussey A. J., Hayes J. D. Characterization of a human class-Theta glutathione S-transferase with activity towards 1-menaphthyl sulphate. Biochem J. 1992 Sep 15;286(Pt 3):929–935. doi: 10.1042/bj2860929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ichiba M., Hagmar L., Rannug A., Högstedt B., Alexandrie A. K., Carstensen U., Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis. 1994 Jul;15(7):1347–1352. doi: 10.1093/carcin/15.7.1347. [DOI] [PubMed] [Google Scholar]
  30. Idle J. R. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res. 1991 Apr;247(2):259–266. doi: 10.1016/0027-5107(91)90021-f. [DOI] [PubMed] [Google Scholar]
  31. Jakoby W. B. The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol. 1978;46:383–414. doi: 10.1002/9780470122914.ch6. [DOI] [PubMed] [Google Scholar]
  32. Kato S., Bowman E. D., Harrington A. M., Blomeke B., Shields P. G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst. 1995 Jun 21;87(12):902–907. doi: 10.1093/jnci/87.12.902. [DOI] [PubMed] [Google Scholar]
  33. Kawajiri K., Eguchi H., Nakachi K., Sekiya T., Yamamoto M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res. 1996 Jan 1;56(1):72–76. [PubMed] [Google Scholar]
  34. Kelsey K. T., Wiencke J. K., Ward J., Bechtold W., Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat Res. 1995 Dec;335(3):267–273. doi: 10.1016/0165-1161(95)00030-5. [DOI] [PubMed] [Google Scholar]
  35. Ketterer B., Harris J. M., Talaska G., Meyer D. J., Pemble S. E., Taylor J. B., Lang N. P., Kadlubar F. F. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect. 1992 Nov;98:87–94. doi: 10.1289/ehp.929887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Khoury M. J., Adams M. J., Jr, Flanders W. D. An epidemiologic approach to ecogenetics. Am J Hum Genet. 1988 Jan;42(1):89–95. [PMC free article] [PubMed] [Google Scholar]
  37. Kihara M., Kihara M., Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis. 1994 Feb;15(2):415–418. doi: 10.1093/carcin/15.2.415. [DOI] [PubMed] [Google Scholar]
  38. Klöne A., Weidner U., Hussnätter R., Harris J., Meyer D., Peter S., Ketterer B., Sies H. Decreased expression of the glutathione S-transferases alpha and pi genes in human renal cell carcinoma. Carcinogenesis. 1990 Dec;11(12):2179–2183. doi: 10.1093/carcin/11.12.2179. [DOI] [PubMed] [Google Scholar]
  39. Liu Y. H., Taylor J., Linko P., Lucier G. W., Thompson C. L. Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis. 1991 Dec;12(12):2269–2275. doi: 10.1093/carcin/12.12.2269. [DOI] [PubMed] [Google Scholar]
  40. McWilliams J. E., Sanderson B. J., Harris E. L., Richert-Boe K. E., Henner W. D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):589–594. [PubMed] [Google Scholar]
  41. Meyer D. J., Coles B., Pemble S. E., Gilmore K. S., Fraser G. M., Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem J. 1991 Mar 1;274(Pt 2):409–414. doi: 10.1042/bj2740409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mooney L. A., Bell D. A., Santella R. M., Van Bennekum A. M., Ottman R., Paik M., Blaner W. S., Lucier G. W., Covey L., Young T. L. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis. 1997 Mar;18(3):503–509. doi: 10.1093/carcin/18.3.503. [DOI] [PubMed] [Google Scholar]
  43. Nakachi K., Imai K., Hayashi S., Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993 Jul 1;53(13):2994–2999. [PubMed] [Google Scholar]
  44. Nakajima T., Elovaara E., Anttila S., Hirvonen A., Camus A. M., Hayes J. D., Ketterer B., Vainio H. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 1995 Apr;16(4):707–711. doi: 10.1093/carcin/16.4.707. [DOI] [PubMed] [Google Scholar]
  45. Natarajan A. T., Boei J. J., Darroudi F., Van Diemen P. C., Dulout F., Hande M. P., Ramalho A. T. Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens. Environ Health Perspect. 1996 May;104 (Suppl 3):445–448. doi: 10.1289/ehp.96104s3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nazar-Stewart V., Motulsky A. G., Eaton D. L., White E., Hornung S. K., Leng Z. T., Stapleton P., Weiss N. S. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 1993 May 15;53(10 Suppl):2313–2318. [PubMed] [Google Scholar]
  47. Nebert D. W. Role of genetics and drug metabolism in human cancer risk. Mutat Res. 1991 Apr;247(2):267–281. doi: 10.1016/0027-5107(91)90022-g. [DOI] [PubMed] [Google Scholar]
  48. Nielsen P. S., Okkels H., Sigsgaard T., Kyrtopoulos S., Autrup H. Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels. Int Arch Occup Environ Health. 1996;68(3):170–176. doi: 10.1007/BF00381627. [DOI] [PubMed] [Google Scholar]
  49. Nielsen P. S., de Pater N., Okkels H., Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers--effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis. 1996 May;17(5):1021–1027. doi: 10.1093/carcin/17.5.1021. [DOI] [PubMed] [Google Scholar]
  50. Olden K. Thinking big: four ways to advance environmental health research to answer the needs of public policy. Environ Health Perspect. 1997 May;105(5):464–465. doi: 10.1289/ehp.97105464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Pearce N., de Sanjose S., Boffetta P., Kogevinas M., Saracci R., Savitz D. Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology. 1995 Mar;6(2):190–194. doi: 10.1097/00001648-199503000-00020. [DOI] [PubMed] [Google Scholar]
  52. Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994 May 15;300(Pt 1):271–276. doi: 10.1042/bj3000271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994 May 15;300(Pt 1):271–276. doi: 10.1042/bj3000271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Perera F. P., Hemminki K., Gryzbowska E., Motykiewicz G., Michalska J., Santella R. M., Young T. L., Dickey C., Brandt-Rauf P., De Vivo I. Molecular and genetic damage in humans from environmental pollution in Poland. Nature. 1992 Nov 19;360(6401):256–258. doi: 10.1038/360256a0. [DOI] [PubMed] [Google Scholar]
  55. Perera F. P. Molecular epidemiology and prevention of cancer. Environ Health Perspect. 1995 Nov;103 (Suppl 8):233–236. doi: 10.1289/ehp.95103s8233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rothman N., Hayes R. B., Zenser T. V., DeMarini D. M., Bi W., Hirvonen A., Talaska G., Bhatnagar V. K., Caporaso N. E., Brooks L. R. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):979–983. [PubMed] [Google Scholar]
  57. Rothman N., Shields P. G., Poirier M. C., Harrington A. M., Ford D. P., Strickland P. T. The impact of glutathione s-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinog. 1995 Sep;14(1):63–68. doi: 10.1002/mc.2940140111. [DOI] [PubMed] [Google Scholar]
  58. Rothman N., Smith M. T., Hayes R. B., Traver R. D., Hoener B., Campleman S., Li G. L., Dosemeci M., Linet M., Zhang L. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997 Jul 15;57(14):2839–2842. [PubMed] [Google Scholar]
  59. Rothman N., Stewart W. F., Schulte P. A. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):301–311. [PubMed] [Google Scholar]
  60. Ryberg D., Skaug V., Hewer A., Phillips D. H., Harries L. W., Wolf C. R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997 Jul;18(7):1285–1289. doi: 10.1093/carcin/18.7.1285. [DOI] [PubMed] [Google Scholar]
  61. Santella R. M., Perera F. P., Young T. L., Zhang Y. J., Chiamprasert S., Tang D., Wang L. W., Beachman A., Lin J. H., DeLeo V. A. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res. 1995 Apr;334(2):117–124. doi: 10.1016/0165-1161(95)90001-2. [DOI] [PubMed] [Google Scholar]
  62. Scarpato R., Hirvonen A., Migliore L., Falck G., Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat Res. 1997 Mar 17;389(2-3):227–235. doi: 10.1016/s1383-5718(96)00152-0. [DOI] [PubMed] [Google Scholar]
  63. Scarpato R., Migliore L., Hirvonen A., Falck G., Norppa H. Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1, and NAT2 genotypes. Environ Mol Mutagen. 1996;27(4):263–269. doi: 10.1002/(SICI)1098-2280(1996)27:4<263::AID-EM3>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  64. Seidegård J., Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect. 1997 Jun;105 (Suppl 4):791–799. doi: 10.1289/ehp.105-1470052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Seidegård J., Pero R. W., Markowitz M. M., Roush G., Miller D. G., Beattie E. J. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis. 1990 Jan;11(1):33–36. doi: 10.1093/carcin/11.1.33. [DOI] [PubMed] [Google Scholar]
  66. Seidegård J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis. 1986 May;7(5):751–753. doi: 10.1093/carcin/7.5.751. [DOI] [PubMed] [Google Scholar]
  67. Shields P. G., Bowman E. D., Harrington A. M., Doan V. T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 1993 Aug 1;53(15):3486–3492. [PubMed] [Google Scholar]
  68. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S. T., Sram R. Assessment of exposure to butadiene in the process industry. Toxicology. 1996 Oct 28;113(1-3):77–83. doi: 10.1016/0300-483x(96)03430-0. [DOI] [PubMed] [Google Scholar]
  69. Srám R. J., Benes I., Binková B., Dejmek J., Horstman D., Kotesovec F., Otto D., Perreault S. D., Rubes J., Selevan S. G. Teplice program--the impact of air pollution on human health. Environ Health Perspect. 1996 Aug;104 (Suppl 4):699–714. doi: 10.1289/ehp.104-1469669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Taningher M., Malacarne D., Mancuso T., Peluso M., Pescarolo M. P., Parodi S. Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies. Mutat Res. 1997 Jun 13;391(1-2):3–32. doi: 10.1016/s0165-1218(97)00026-8. [DOI] [PubMed] [Google Scholar]
  71. Topinka J., Binková B., Mracková G., Stávková Z., Benes I., Dejmek J., Lenícek J., Srám R. J. DNA adducts in human placenta as related to air pollution and to GSTM1 genotype. Mutat Res. 1997 Apr 24;390(1-2):59–68. doi: 10.1016/s0165-1218(96)00166-8. [DOI] [PubMed] [Google Scholar]
  72. Vineis P., Martone T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology. 1995 Jul;6(4):455–457. doi: 10.1097/00001648-199507000-00026. [DOI] [PubMed] [Google Scholar]
  73. Warholm M., Guthenberg C., Mannervik B. Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry. 1983 Jul 19;22(15):3610–3617. doi: 10.1021/bi00284a011. [DOI] [PubMed] [Google Scholar]
  74. Warwick A., Sarhanis P., Redman C., Pemble S., Taylor J. B., Ketterer B., Jones P., Alldersea J., Gilford J., Yengi L. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis. 1994 Dec;15(12):2841–2845. doi: 10.1093/carcin/15.12.2841. [DOI] [PubMed] [Google Scholar]
  75. Wiencke J. K., Kelsey K. T., Lamela R. A., Toscano W. A., Jr Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res. 1990 Mar 1;50(5):1585–1590. [PubMed] [Google Scholar]
  76. Wolff S., Jostes R., Cross F. T., Hui T. E., Afzal V., Wiencke J. K. Adaptive response of human lymphocytes for the repair of radon-induced chromosomal damage. Mutat Res. 1991 Sep-Oct;250(1-2):299–306. doi: 10.1016/0027-5107(91)90185-q. [DOI] [PubMed] [Google Scholar]
  77. Yu M. C., Ross R. K., Chan K. K., Henderson B. E., Skipper P. L., Tannenbaum S. R., Coetzee G. A. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):861–864. [PubMed] [Google Scholar]
  78. Zhong S., Howie A. F., Ketterer B., Taylor J., Hayes J. D., Beckett G. J., Wathen C. G., Wolf C. R., Spurr N. K. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis. 1991 Sep;12(9):1533–1537. doi: 10.1093/carcin/12.9.1533. [DOI] [PubMed] [Google Scholar]
  79. Zhong S., Howie A. F., Ketterer B., Taylor J., Hayes J. D., Beckett G. J., Wathen C. G., Wolf C. R., Spurr N. K. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis. 1991 Sep;12(9):1533–1537. doi: 10.1093/carcin/12.9.1533. [DOI] [PubMed] [Google Scholar]
  80. van Poppel G., Verhagen H., van 't Veer P., van Bladeren P. J. Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase mu. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):441–447. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES